EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Pediatric acute myeloid leukemia with t(8;21) and KIT mutation treatment with avapritinib post-stem cell transplantation: a report of four cases

Qingwei Wang, Yixin Hu, Li Gao, Senlin Zhang, Jun Lu, Bohan Li, Jie Li, Yanhua Yao, Shengqin Cheng, Peifang Xiao, Shaoyan Hu

Annals of Hematology · 2024

DOI: 10.1007/s00277-024-05810-z ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of Hematology, 2024. Verfasst von Qingwei Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215000, China. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Proto-Oncogene Proteins c-kit, Translocation, Genetic, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, Jiangsu key project, Suzhou project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myeloid leukemia (AML) with t(8;21) (q22;q22), which forms RUNX1::RUNX1T1 fusion gene, is classified as a favorable-risk group. However, the presence of mutations in KIT exon 17 results in an adverse prognosis in this group. Avapritinib, a novel tyrosine kinase inhibitor, was designed to target KIT mutation. We report a retrospective study of four pediatric patients with AML with t(8:21) and KIT exon 17 mutation who were treated with avapritinib, three of them failed to demethylate drugs and donor lymphocyte infusion targeting RUNX1::RUNX1T1 -positivity after allogeneic hematopoietic stem cell transplantation (allo-HSCT). So far, all patients with RUNX1::RUNX1T1 positivity had turned negative after 1, 9, 7, 2 months of avapritinib treatment. The common adverse effect of avapritinib is neutropenia, which is well-tolerated. This case series indicates that avapritinib may be effective and safe for preemptive treatment of children with AML with t(8;21) and KIT mutation after allo-HSCT, providing a treatment option for preventing relapse after allo-HSCT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteProto-Oncogene Proteins c-kitTranslocation, GeneticHematopoietic Stem Cell TransplantationMutationChromosomes, Human, Pair 21Chromosomes, Human, Pair 8HumansMaleFemaleChildChild, PreschoolPyrazinesAdolescentPyrazolesOncogene Proteins, FusionRetrospective StudiesPyrrolesCore Binding Factor Alpha 2 SubunitTriazinesAvapritinib

Stichwörter der Autor:innen

KIT mutationAcute myeloid leukemiaAvapritinibPediatrict(8;21)

Substanzen

Proto-Oncogene Proteins c-kitPyrazinesPyrazolesOncogene Proteins, FusionPyrrolesCore Binding Factor Alpha 2 SubunitTriazinesAvapritinibKIT protein, human

Autor:innen und Institutionen

  • Department of Hematology and Oncology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215000, China.
  • Department of Hematology and Oncology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215000, China. xpfdr@163.com.
  • Department of Hematology and Oncology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215000, China. hushaoyan@suda.edu.cn.

Förderung

  • the National Natural Science Foundation of China
  • Jiangsu key project
  • Suzhou project
  • National Clinical Research Center for Hematologic Disease

Zitieren

APA

Wang, Q., Hu, Y., Gao, L., Zhang, S., Lu, J., Li, B., Li, J., Yao, Y., Cheng, S., Xiao, P., & Hu, S. (2024). Pediatric acute myeloid leukemia with t(8;21) and KIT mutation treatment with avapritinib post-stem cell transplantation: a report of four cases. Annals of Hematology. https://doi.org/10.1007/s00277-024-05810-z

Vancouver

Wang Q, Hu Y, Gao L, Zhang S, Lu J, Li B, et al. Pediatric acute myeloid leukemia with t(8;21) and KIT mutation treatment with avapritinib post-stem cell transplantation: a report of four cases. Annals of Hematology. 2024. doi:10.1007/s00277-024-05810-z

BibTeX
@article{Wang2024,
  author = {Wang, Qingwei and Hu, Yixin and Gao, Li and Zhang, Senlin and Lu, Jun and Li, Bohan and Li, Jie and Yao, Yanhua and Cheng, Shengqin and Xiao, Peifang and Hu, Shaoyan},
  title = {Pediatric acute myeloid leukemia with t(8;21) and KIT mutation treatment with avapritinib post-stem cell transplantation: a report of four cases},
  journal = {Annals of Hematology},
  year = {2024},
  doi = {10.1007/s00277-024-05810-z}
}
Kostenlos starten →